Role of organotellurium species in tellurium neuropathy

Neurochemical Research

Volumn 23, Issue 10, 1998, Pages 1313-1319

  Goodrum, Jeffry F ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Active species; Biotransformation; Cholesterol synthesis; Demyelination; Neurotoxicity; Squalene epoxidase

Indexed keywords

DIMETHYLTELLURIDE; DIMETHYLTELLURONIUM CHLORIDE; ORGANOTELLURIUM DERIVATIVE; POTASSIUM TELLURITE; SQUALENE MONOOXYGENASE; TELLURIUM DERIVATIVE; TRIMETHYLTELLURONIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEMYELINATION; ENZYME INHIBITION; IN VIVO STUDY; NERVE CELL CULTURE; NEWBORN; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RAT; SCHWANN CELL; SCIATIC NERVE;

ANIMALS; CHOLESTEROL; DEMYELINATING DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; RATS; SCHWANN CELLS; TELLURIUM;

ANIMALIA;

EID: 0031759020     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020704502586     Document Type: Article

References (23)

1. Lampert, P., Garro, F., and Pentschew, A 1970. Tellurium neuropathy. Acta Neuropathol. (Berl) 15:308-317.
2. Lampert, P. W., and Garrett, R. S. 1971. Mechanism of demyelination in tellurium neuropathy. Electron microscopic observations. Lab. Invest. 25:380-388.
3. Miyoshi, K., and Takauchi, S. 1977. Chronic tellurium intoxication in rats. Folia Psychiatr. Neurol. Jpn. 31:111-118.
4. Duckett, S,. Said, G., Streletz, L. G., White, R. G., and Galle, P. 1979. Tellurium-induced neuropathy: correlative physiological, morphological and electron microprobe studies. Neuropathol. Appl. Neurobiol. 5:265-178.
5. Said, G., Duckett, S., and Sauron, B. 1981. Proliferation of Schwann cells in tellurium-induced demyelination in young rats. A radioautographic and teased fiber study. Acta Neuropathol. (Berl.) 53:173-179.
6. Takahashi, T. 1981. Experimental study on segmental demyelination in tellurium neuropathy. Hokkaido Igaku. Zasshi. 56:105-131.
7. Wiley-Livingston, C. A., and Ellisman, M. H. 1982. Return of axonal and glial membrane specializations during remyelination after tellurium-induced demyelination. J. Neurocytol. 11:65-80.
8. Bouldin, T. W., Samsa, G., Earnhardt, T. S., and Krigman, M. R. 1988. Schwann cell vulnerability to demyelination is associated with internodal length in tellurium neuropathy. J. Neuropathol. Exp. Neurol. 47:41-47.
9. Toews, A. D., Goodrum, J. F., Lee, S. Y., Eckermann, C., and Morell, P. 1991. Tellurium-induced alterations in 3-hydroxy-3-methylglutaryl-CoA reductase gene expression and enzyme activity: differential effects in sciatic nerve and liver suggest tissue-specific regulation of cholesterol synthesis. J. Neurochem. 57:1902-1906.
10. Toews, A. D., Griffiths, I. R., Kyriakides, E., Goodrum, J. F., Eckermann, C. E. Morell, P., and Thomson, C. E. 1992. Primary demyelination induced by exposure to tellurium alters Schwann-cell gene expression. A model for intracellular targeting of NGF receptor. J. Neuroscience 12:3676-3687.
11. Said, G., and Duckett, S. 1981. Tellurium-induced myelinopathy in adult rats. Muscle & Nerve 4:319-325.
12. Harry, G. J., Goodrum, J. F., Bouldin, T. W., Wagner-Recio, M., Toews, A. D., and Morell, P. 1989. Tellurium-induced neuropathy: metabolic alterations associated with demyelination and remyelination in rat sciatic nerve. J. Neurochem. 52:938-945.
13. Goodrum, J. F., Earnhardt, T. S., Goines, N. D., and Bouldin, T. W. 1990. Lipid droplets in Schwann cells during tellurium neuropathy are derived from newly synthesized lipid. J. Neurochem. 55:1928-1932.
14. Wagner-Recio, M., Toews, A. D., and Morell, P. 1991. Tellurium blocks cholesterol synthesis by inhibiting squalene metabolism: preferential vulnerability to this metabolic block leads to peripheral nervous system demyelination. J. Neurochem. 57:1891-1901.
15. Wagner, M., Toews, A. D., and Morell, P. 1995. Tellurite specifically affects squalene epoxidase: investigations examining the mechanism of tellurium-induced neuropathy. J. Neurochem. 64: 2169-2176.
16. Morell, P. 1994. Biochemical and molecular bases of myelinopathy. Pages 583-608, in Chang, L.W. (ed.), Principles of Neurotoxicology, Marcel Dekker, Inc., New York.
17. Braheny, S. L., and Lampert, P. W. 1980. Tellurium. Pages 558-569, in Spencer, P.S., and Schaumburg, H.H. (eds.), Experimental and Clinical Neurotoxicology, Williams and Wilkins, Baltimore.
18. Neuberger, T. J., Kalimi, O., Regelson, W., Kalimi, M., and DeVries, G. 1994. Glucocoritcoids enhance the potency of Schwann cell mitogens. J. Neurosci. Res. 38:300-313.
19. Brockes, J. P., Fields, K. L., and Raff, M. C. 1979. Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerves. Brain Res. 165:105-118.
20. Turner, R. J., Weiner, J. H., and Taylor, D. E. 1992. Use of diethyldithiocarbamate for quantitative determination of tellurite uptake by bacteria. Analyt. Biochem. 204:292-295.
21. Amdur, M. L. 1947. Tellurium: accidental exposure and treatment with BAL in oil. Occup. Med. 3:386-391.
22. Fishbein, L. 1977. Toxicology of selenium and tellurium. Pages 191-240, in Goyer, R. A., and Mehlman, M. A. (eds.), Advances in Modern Toxicology Vol. II., John Wiley & Sons, New York.
23. De Meio, R. H. 1946. Tellurium I. The toxicity of ingested elementary tellurium for rats and rat tissues. J. Indust. Hyg. Toxicol. 28:299-304.